|
Originally published In Press as doi:10.1194/jlr.M600326-JLR200 on November 1, 2006
Papers In Press, published online ahead of print February 1, 2007
J. Lipid Res., doi:10.1194/jlr.M600326-JLR200
Journal of Lipid Research, Vol. 48, 405-416, February 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways
Yi Zhang*,
Ayesha M. Ahmed*,
Nicole McFarlane ,
Christina Capone*,
Douglas R. Boreham ,
Ray Truant*,
Suleiman A. Igdoura and
Bernardo L. Trigatti1,*
* Departments of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada
Departments of Medical Physics and Applied Radiation Sciences, McMaster University, Hamilton, Ontario, Canada
Departments of Biology and Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of videos.
Published, JLR Papers in Press, November 1, 2006.
1 To whom correspondence should be addressed. e-mail: trigatt{at}mcmaster.ca
Scavenger receptor, class B, type I (SR-BI) mediates binding and internalization of a variety of lipoprotein and nonlipoprotein ligands, including HDL. Studies in genetically engineered mice revealed that SR-BI plays an important role in HDL reverse cholesterol transport and protection against atherosclerosis. Understanding how SR-BI's function is regulated may reveal new approaches to therapeutic intervention in atherosclerosis and heart disease. We utilized a model cell system to explore pathways involved in SR-BI-mediated lipid uptake from and signaling in response to distinct lipoprotein ligands: the physiological ligand, HDL, and a model ligand, acetyl LDL (AcLDL). In Chinese hamster ovary-derived cells, murine SR-BI (mSR-BI) mediates lipid uptake via distinct pathways that are dependent on the lipoprotein ligand. Furthermore, HDL and AcLDL activate distinct signaling pathways. Finally, mSR-BI-mediated selective lipid uptake versus endocytic uptake are differentially regulated by protein kinase signaling pathways. The protein kinase C (PKC) activator PMA and the phosphatidyl inositol 3-kinase inhibitor wortmannin increase the degree of mSR-BI-mediated selective lipid uptake, whereas a PKC inhibitor has the opposite effect. These data demonstrate that SR-BI's selective lipid uptake activity can be acutely regulated by intracellular signaling cascades, some of which can originate from HDL binding to murine SR-BI itself.
Supplementary key words acetyl LDL endocytosis HDL lipoprotein phosphatidyl inositol 3-kinase protein kinase C scavenger receptor, class B, type I Abbreviations: AcLDL, acetyl LDL; apo, apolipoprotein; CHO, Chinese hamster ovary; CTX-B, cholera toxin subunit B; DiI, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; ERK, extracellular signal-regulated kinase; KFM, potassium-free medium; MAPK, mitogen-activated protein kinase; MARCKS, myristoylated alanine-rich C-kinase substrate; mSR-AI, murine scavenger receptor, class A, type I; mSR-BI, murine scavenger receptor, class B, type I; PI3K, phosphatidyl inositol 3-kinase; PKC, protein kinase C; SR-AI, scavenger receptor, class A, type I; SR-BI, scavenger receptor, class B, type I

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Itoh, A. Watanabe, K. Funami, T. Seya, and M. Matsumoto
The Clathrin-Mediated Endocytic Pathway Participates in dsRNA-Induced IFN-{beta} Production
J. Immunol.,
October 15, 2008;
181(8):
5522 - 5529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Minahk, K.-W. Kim, R. Nelson, B. Trigatti, R. Lehner, and D. E. Vance
Conversion of Low Density Lipoprotein-associated Phosphatidylcholine to Triacylglycerol by Primary Hepatocytes
J. Biol. Chem.,
March 7, 2008;
283(10):
6449 - 6458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. F. Nieland, J. T. Shaw, F. A. Jaipuri, Z. Maliga, J. L. Duffner, A. N. Koehler, and M. Krieger
Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI
J. Lipid Res.,
August 1, 2007;
48(8):
1832 - 1845.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|